Institution
Peking University Shenzhen Hospital
Also known as: Shenzhen Central Hospital · 北京大学深圳医院
- 101running trials
- 18closed trials
- 9,125publications (OpenAlex)
Running trials
Not yet recruiting
Molecular Subtype-Guided Postoperative Radiotherapy for Phyllodes Tumor of the Breast
Recruiting
Not yet recruiting
Recruiting
Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis
Not yet recruiting
Recruiting
Not yet recruiting
Recruiting
Mindfulness Intervention for Emotional Distress (MIED) in Patients With GERD
Not yet recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Not yet recruiting
Recruiting
Recruiting
Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma
Recruiting
Recruiting
Dual-Target CAR-NK Cells in Recurrent or Refractory Epithelial Ovarian Cancer
Recruiting
SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus
Recruiting
Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
Recruiting
Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer
Recruiting
Dual-Target CAR-NK Cells Targeting MSLN, EGFR, or HER2 in Advanced NSCLC
Recruiting
Recruiting
Recruiting
EGFR/HER2 Dual-Target CAR-NK Cells for Recurrent or Metastatic HNSCC
Recruiting
Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) pt2
Recruiting
Dual-Target CLDN18.2/HER2 CAR-NK Cells for Advanced Esophageal Adenocarcinoma
Recruiting
Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies
Recruiting
Dual-target CLDN18.2/HER2 CAR-NK Cells for Advanced Gastric/GEJ Cancer
Recruiting
Recruiting
Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma
Recruiting
Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors
Recruiting
Dual-target PSMA/PSCA CAR-NK Cells in Advanced Prostate Cancer
Recruiting
Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma
Recruiting
Recruiting
Effect of Retatrutide Versus Placebo in Participants Who Have Obesity or Are Overweight
Recruiting
Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16)
Recruiting
Dual-Targeting CAR-NK Cell Therapy for Recurrent/Progressive Glioblastoma and High-Grade Glioma
Recruiting
Recruiting
Recruiting
Recruiting
MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity
Recruiting
Dual-target CD70/CAIX CAR-NK Cells for Advanced Clear Cell Renal Cell Carcinoma
Recruiting
Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC
Recruiting
Dual-Targeting CAR-NK Cells in Biomarker-Selected Advanced Colorectal Cancer
Recruiting
Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)
Recruiting
Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease
Recruiting
Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)
Recruiting
Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC
Showing 50 of 101.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer9 recruiting
- Ovarian cancer5 recruiting
- Gastric and oesophageal cancer4 recruiting
- Liver and biliary tract cancer4 recruiting
- Multiple myeloma4 recruiting
- Obesity4 recruiting
- Childhood cancers3 recruiting
- Colorectal cancer3 recruiting
- Fatty liver disease (MASLD/MASH)3 recruiting
- Glioblastoma3 recruiting
- Metastatic breast cancer3 recruiting
- Pancreatic cancer3 recruiting
- Prostate cancer3 recruiting
- Triple-negative breast cancer3 recruiting
- COPD2 recruiting
- Head and neck cancer2 recruiting
- Hepatitis B2 recruiting
- IgA nephropathy2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Acute myeloid leukaemia1 recruiting
- Alzheimer disease1 recruiting
- Amyloidosis1 recruiting
- ANCA-associated vasculitis1 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Bladder cancer1 recruiting
- Bronchiectasis1 recruiting
- Cervical cancer1 recruiting
- Chronic kidney disease1 recruiting
- Coronary artery disease1 recruiting
- Crohn's disease1 recruiting
- Kidney cancer1 recruiting
- Liver cirrhosis1 recruiting
- Lupus (SLE)1 recruiting
- Melanoma1 recruiting
- Mesothelioma1 recruiting
- Myelodysplastic syndromes1 recruiting
- Neuroblastoma1 recruiting
- Primary biliary cholangitis1 recruiting
- Rheumatoid arthritis1 recruiting
- Thymoma and thymic carcinoma1 recruiting
- Type 2 diabetes1 recruiting
- Ulcerative colitis1 recruiting
- Vitiligo1 recruiting
Closed trials
Withdrawn
Completed
Completed
Completed
Terminated
A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)
Completed
Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001
Completed
Completed
Completed
Completed
Completed
Zanubrutinib in Participants With Active Proliferative Lupus Nephritis
Completed
Completed
Completed
Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab
Completed
Completed
Completed
Terminated
Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
Registry name variants (7)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Peking University Shenzhen Hospital
Shenzhen, Guangdong 518036
114 trials
Peking University Shenzhen Hospital, China
Shenzhen, Guangdong
1 trial
NCT04162353BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma
Contact: Hongyu Zhang, MD/PhD
Peking University Shenzhen Hospital (Site 2442)
Shenzhen, Guangdong 518036
1 trial
Peking University Shenzhen Hospital (Site 3118)
Shenzhen, Guangdong 518036
1 trial
Peking University Shenzhen Hospital (Site 3216)
Shenzhen, Guangdong 518036
1 trial
Peking University Shenzhen Hospital - Site #43
Shenzhen, Guangdong 518036
1 trial
Shenzhen Hospital of Peking University
Shenzhen, Guangdong
1 trial
NCT06423235Efficacy and Safety of Prunella Oral Liquid in the Treatment of Thyroid Nodules
Contact: Fan Zhang (sub-investigator)
Conditions
Diseases this institution publishes on or runs trials for.
- Lupus (SLE)20 works · 3 trials
- IgA nephropathy7 works · 6 trials
- Graves' disease4 works · 0 trials
Institution data: ROR 03kkjyb15 (CC0-1.0)Updated 15 Nov 2026